Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,956 | -1,330 | 31,011 | 18,289 | 24,068 |
| Depreciation Amortization | 56,325 | 28,152 | 116,048 | 93,243 | 64,017 |
| Income taxes - deferred | 1,173 | -3,504 | 4,208 | -4,796 | 2,135 |
| Accounts receivable | 4,100 | 3,849 | 3,065 | 4,562 | 1,200 |
| Other Working Capital | 38,719 | 21,213 | 73,324 | 54,944 | 26,480 |
| Other Operating Activity | 27,265 | 11,745 | 26,341 | 21,960 | -7 |
| Operating Cash Flow | $125,626 | $60,125 | $253,997 | $188,202 | $117,893 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -28,621 | 325 | -34,419 | -37,139 | -35,406 |
| PPE Investments | 15,356 | -3,276 | -237,119 | -78,263 | -11,328 |
| Other Investing Activity | 10,180 | 42 | 123,093 | 1,520 | -114 |
| Investing Cash Flow | $-3,085 | $-2,909 | $-148,445 | $-113,882 | $-46,848 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 227,000 | 110,000 | 705,045 | 581,582 | 468,082 |
| Debt Repayment | -346,200 | -102,681 | -631,875 | -614,006 | -490,319 |
| Common Stock Issued | 229 | 113 | 1,285 | 532 | 335 |
| Common Stock Repurchased | N/A | N/A | -34,118 | -34,118 | -34,118 |
| Dividend Paid | -4,414 | -2,207 | -8,829 | -6,621 | -4,414 |
| Other Financing Activity | -2,156 | -1,061 | -139,987 | -768 | -496 |
| Financing Cash Flow | $-125,541 | $4,164 | $-108,479 | $-73,399 | $-60,930 |
| Exchange Rate Effect | -189 | -77 | 183 | -874 | -77 |
| Beginning Cash Position | 73,239 | 73,239 | 75,983 | 75,983 | 75,983 |
| End Cash Position | 70,050 | 134,542 | 73,239 | 76,030 | 86,021 |
| Net Cash Flow | $-3,189 | $61,303 | $-2,744 | $47 | $10,038 |
| Free Cash Flow | |||||
| Operating Cash Flow | 125,626 | 60,125 | 253,997 | 188,202 | 117,893 |
| Capital Expenditure | -32,930 | -27,810 | -318,811 | -337,265 | -231,731 |
| Free Cash Flow | 92,696 | 32,315 | -64,814 | -149,063 | -113,838 |